| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |